Excellence in Dermatology™
Excellence in Dermatologic Surgery™
Excellence in Medical Dermatology™
Excellence in Dermatopathology™

S025 - Acne and Rosacea

Saturday, February 17; 9:00 AM - 12:00 PM

Learning Objectives

Following this course, the attendee should be able to:

  • Discuss the latest understanding of the pathophysiology of acne and rosacea
  • Analyze the latest treatment options in acne and rosacea
  • Discuss the role of lasers in the management of rosacea


We will review the latest in the understanding of the pathogenesis of acne and rosacea. We will analyze the latest treatment options including medical and surgical approaches.


  • Alexis, Andrew F., MD: Allergan, Inc – I(Grants/Research Funding); Allergan, Inc. – A(H); Anacor Pharmaceuticals, Inc. – A(H); Aqua – C(Fees); BioPharmX – C(Fees), I(Grants/Research Funding); Dermira – I(Grants/Research Funding); Galderma Laboratories, L.P. – A(H), I(Grants/Research Funding); L'Oreal USA Inc. – A(H), C(Fees), SP(H); Leo Pharma Inc. – A(H); Menlo Therapeutics – A(H); Novan – C(Fees), I(Grants/Research Funding); Novartis – C(Fees), Speaker/Faculty Education(H); Novartis Pharmaceuticals Corp. – I(Grants/Research Funding); Pfizer Inc. – A(H); Regeneron – A(H); Roche Laboratories – C(Fees); RXi Pharmaceuticals Corporation – I(Grants/Research Funding); Sanofi/Regeneron – A(H); Sanova Works – SP(H); Solta Medical – O(EQ); Springer Science & Business Media – O(OB); Unilever – A(H); Valeant Pharmaceuticals North America LLC – A(H); Wiley-Blackwell – O(OB);
  • Baldwin, Hilary E., MD: Allergan, Inc. – A(H); Bayer – SP(NC); Dermira – I(Grants/Research Funding); Galderma Laboratories, L.P. – SP(H); Novan – I(Grants/Research Funding); Sun Pharmaceutical Industries Ltd. – SP(H); Valeant Pharmaceuticals International – SP(H);
  • Cohen, David Eric, MD: Bickel Biotechnology – B(SO); Celgene – A(H); Cutanea Life Sciences – A(H); Dermira – B(Fees), B(ST); Facilitation of International Dermatology Education – C(H); Ferndale Laboratories, Inc. – C(H); Ferrer – A(H); Medimetriks Pharmaceuticals, Inc. – C(H), C(SO); Novartis – C(H);
  • Gallo, Richard L., MD, PhD: Allergan, Inc. – I(Grants/Research Funding); Colgate-Palmolive – I(Grants/Research Funding); Hoffman-La Roche Ltd. – C(H); Johnson and Johnson – A(H); MatriSys Bioscience – F(SO); Sente Labs – C(Fees);
  • Harper, Julie Claire, MD: Aclaris Therapeutics Inc. – A(H); Allergan, Inc – SP(H); Aqua – C(H); Bayer Pharmaceuticals – I(Fees), O(H); BioPharmX – A(H); Dermira – A(H); Galderma Laboratories, L.P. – C(H); Galderma USA – SP(H); La Roche-Posay Laboratoire Pharmaceutique – SP(H); Novan – A(H); Promius Pharma, LLC – SP(H); Sun Pharmaceutical Industries Ltd. – C(Fees); Taro Pharm – A(H); Valeant Pharmaceuticals North America LLC – SP(H);
  • Leyden, James Joseph, MD: Avon Products, Inc. – C(H); BioPharmX – C(H); Cutanea Life Sciences – C(H); Galderma Laboratories, L.P. – C(H); Photosonix – C(H); Sol-Gel Technologies – C(H); Unilever Home & Personal Care USA – C(H);
  • Stein Gold, Linda F., MD: AbbVie – A(H); Actavis – SP(H); Allergan, Inc. – I(Grants/Research Funding); Aqua – A(H); Ferndale Laboratories, Inc. – C(H); Foamix – A(H); Galderma Laboratories, L.P. – A(H), I(Grants/Research Funding); La Roche-Posay Laboratorie Pharmaceutique – A(H); Leo Pharma Inc. – I(Grants/Research Funding); LEO Pharma, US – A(H); Lilly ICOS LLC – A(H); Medicis Pharmaceutical Corporation – A(H); Merz Pharmaceuticals, LLC – A(H); Novartis Pharmaceuticals Corp. – I(Grants/Research Funding); Pfizer Inc. – A(H), I(Grants/Research Funding); Promius Pharmaceuticals – A(H); Roche Laboratories – Independent Contractor(Fees), O(H); Sol-Gel Technologies – C(Grants/Research Funding); Stiefel a GSK company – A(H); Taro Pharm – A(H), C(H); Topica – I(Grants/Research Funding); Valeant Pharmaceuticals International – A(H), I(Grants/Research Funding);
  • Tanghetti, Emil A., MD: Accure Medical, LLC – I(Grants/Research Funding); Allergan, Inc. – A(H), C(H), I(Grants/Research Funding), SP(H); Amgen – I(Grants/Research Funding); Bayer – SP(H); Celgene Corporation – I(Grants/Research Funding); Coherus Biosciences – I(Grants/Research Funding); Cynosure, Inc. – C(EQ), I(EQ); DUSA Pharmaceuticals, Inc. – C(H), I(Grants/Research Funding), SP(H); Galderma Research & Development, LLC – C(H), I(Grants/Research Funding), SP(H); Leo Pharma A/S – I(Grants/Research Funding); Leo Pharma Inc – SP(H); Lilly ICOS LLC – I(Grants/Research Funding); Valeant Pharmaceuticals International – I(Grants/Research Funding), SP(H);
  • Webster, Guy F., MD, PhD: AbbVie – A(Fees); Aclaris Therapeutics Inc. – C(Fees); Allergan, Inc. – A(Fees); Anterios Inc. – C(Fees); BioPharmX – C(H); Cutanea Life Sciences – C(Fees); Dermira – C(Fees), SH(ST); Foamix – C(Fees); Galderma Laboratories, L.P. – C(Fees); Janssen Pharmaceuticals, Inc – C(Fees); OPKO Health, Inc – SH(NC); Ralexar Therapeutics, Inc – C(Fees); Ranbaxy Laboratories Limited – C(Fees); Sienna Biopharmaceuticals – SH(ST); Sol-Gel Technologies – C(Fees); Valeant Pharmaceuticals International – C(Fees);
Saturday, February 17
9:00 AM
Dr. Gallo / What's New in the Pathophysiology of Acne
9:20 AM
Dr. Baldwin / Cutting Edge Acne Treatments
9:35 AM
Dr. Harper / Treating Acne in Women, Special Considerations
9:50 AM
Dr. Alexis / Getting the Best Results in our Patients with Skin of Color
10:05 AM
Dr. Gallo, Dr. Baldwin, Dr. Harper, and Dr. Alexis / Q and A
10:15 AM
Dr. Cohen / Update on the Pathophysiology of Rosacea
10:35 AM
Dr. Stein Gold / Treating Rosacea: What have we learned in 2018
10:55 AM
Dr. Webster / Challenging Cases in Acne and Rosacea
11:10 AM
Dr. Tanghetti / Devices in Acne and rosacea
11:25 AM
Dr. Leyden / What I have learned over a career in Acne and Rosacea
11:45 AM
All faculty / Q and A
Event Details
  • Date
    Saturday, February 17
  • Time
    9:00 AM - 12:00 PM
  • Location
    Room 1A
  • CME Credits
  • Type
  • Linda F. Stein Gold, MD, FAAD
  • Andrew F. Alexis, MD, FAAD
  • David Eric Cohen, MD, FAAD
  • Emil A. Tanghetti, MD, FAAD
  • Guy F. Webster, MD, PhD, FAAD
  • Hilary E. Baldwin, MD, FAAD
  • James Joseph Leyden, MD, FAAD
  • Julie Claire Harper, MD, FAAD - Handout
  • Richard L. Gallo, MD, PhD, FAAD